U.S. market Closed. Opens in 9 hours 16 minutes

DSGN | Design Therapeutics, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 5.89 - 6.30
52 Week Range 2.2450 - 7.77
Beta 2.08
Implied Volatility 318.29%
IV Rank 19.96%
Day's Volume 121,741
Average Volume 239,274
Shares Outstanding 56,621,000
Market Cap 355,579,880
Sector Healthcare
Industry Biotechnology
IPO Date 2021-03-29
Valuation
Profitability
Growth
Health
P/E Ratio -7.39
Forward P/E Ratio N/A
EPS -0.85
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 57
Country USA
Website DSGN
Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ systems dependent on mitochondrial function, eventually leading to neurological, cardiac, and metabolic dysfunction; and Myotonic Dystrophy Type-1 (DM1), a dominantly-inherited, monogenic progressive neuromuscular disease affecting skeletal muscle, heart, brain, and other organs. It is also developing GeneTAC product candidate portfolio for the treatment of other nucleotide repeat expansion-driven monogenic diseases, such as Fragile X syndrome, spinocerebellar ataxias, amyotrophic lateral sclerosis, frontotemporal dementia, Huntington disease, and spinobulbar muscular atrophy. Design Therapeutics, Inc. was incorporated in 2017 and is headquartered in Carlsbad, California.
*Chart delayed
Analyzing fundamentals for DSGN we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is strong. For more detailed analysis please see DSGN Fundamentals page.

Watching at DSGN technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on DSGN Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙